Financials
- Market Capitalization 2.37 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-63.2
ratio cours/chiffre d'affaires
5.56
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1856 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.60 USD | +1.57% | -6.98% | +78.95% | +608.33% | 2.53 B USD | ||
| 1860 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.45 USD | -2.98% | -12.26% | +3.96% | +8.00% | 2.40 B USD | ||
| 1880 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.09 USD | +0.48% | -4.74% | +36.39% | +105.98% | 2.40 B USD | ||
| 1884 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 39.62 USD | -0.75% | -8.92% | +23.89% | -8.69% | 2.36 B USD |